Discussion Our findings in context In the SURPASS clinical trial program, tirzepatide at all doses studied (5 mg, 10 mg, and 15 mg) demonstrated clinically relevant reductions in the prevalence of patients meeting the criteria for metabolic syndrome following 40 or 52 weeks of treatment
Prioritize fiber and protein: While a low-calorie diet is recommended, that doesnt mean someone should skimp on fiber, which can help reduce gastrointestinal side effects, and protein, which can help preserve muscle
OXIDATIVE STRESS, INSULIN SIGNALING AND DIABETES Hristov, B.D
All information provided supports scientific and educational purposes
At 2 mg per week (the starting dose), one vial provides five doses across five weeks